Not long after Librela's FDA approval, Facebook and other social media groups began forming about serious side effects.

In a recent “Dear Veterinarian” letter, the FDA alerted veterinarians of adverse events in dogs treated with bedinvetmab ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

"Pill testing does exist in many other jurisdictions around the country and around the world, so we know 10 to 20 per cent of people throw away their pill after it's been tested, we know drug ...

Chinese-owned carmaker MG looks to be closer to officially unveiling a new ute, and its upcoming dual-cab could be the one which finally comes to Australia. CarNewsChina shared a photo of what’s ...

Of the teenagers she sampled, 10 percent reported purchasing drugs via social media. “Those exposed to drug ads were 17 times more likely to purchase drugs on social media compared to those who ...

The drug bazaar that powered this part of southern ... taxing goods to the tune of $10 million a month or more, according to Taliban officials. “The money from agriculture, poppy included ...

The Fire HD 8 is down to $54.99 (that’s 45% off), and the Fire HD 10 is just $74.99 (46% off). These tablets are great for streaming, getting basic tasks done, or just relaxing with your ...

MG has returned to the South African new-vehicle market! Our regular contributor, Calvin Fisher, recently travelled to China to spend some quality time at the helm of the MG HS – the Chinese brand’s ...

Merck announced on Wednesday that it has inked a global licensing partnership with Chinese biotech Hansoh Pharma to advance a GLP-1 receptor agonist pill, jumping into an already-crowded space of oral ...

The US Food and Drug Administration has placed its most serious warning – a so-called black-box warning – on a drug used to relieve menopausal hot flashes. The FDA says women who are taking ...

Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass ...